Revolution Medicines, Inc Warrant

Yahoo Finance • last month

Piper Sandler Initiates Coverage of Revolution Medicines (RVMD) with an Overweight Rating

Revolution Medicines, Inc. (NASDAQ:RVMD) is one of the most promising future stocks according to Wall Street analysts. On August 18, Piper Sandler initiated coverage of Revolution Medicines, Inc. (NASDAQ:RVMD) with an Overweight rating and... Full story

Yahoo Finance • 2 months ago

Revolution Medicines outlines $1.03B–$1.09B net loss guidance for 2025 amid expanded global RAS portfolio strategy

Earnings Call Insights: Revolution Medicines (RVMD) Q2 2025 MANAGEMENT VIEW * CEO Mark A. Goldsmith outlined progress across Revolution Medicines’ RAS(ON) inhibitor pipeline, highlighting “a compelling pipeline of 3 distinguished clini... Full story